JNJ
stock NYSEKey stats
- Open
- $229.31
- -0.00%
- Close
- $231.73
- +1.05%
- Current
- $231.73
- Prev close
- $229.32
- Today
- 5.24M
- 3-mo avg
- 7.93M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 21x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.2% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 28.5% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 32.9% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 13.5% return on assets is strong; the company squeezes good profit from its assets.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 1.44, the company carries a moderate, manageable amount of debt.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.03, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 6.0% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 90.6% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |
| Net income | $14.7B | $20.9B | $35.2B | $14.1B | $26.8B |
| Diluted EPS | $5.51 | $7.81 | $13.72 | $5.79 | $11.03 |
| Dividend / share | $3.98 | $4.19 | $4.70 | $4.91 | $5.14 |
| Total assets | $174.9B | $182.0B | $167.6B | $180.1B | $199.2B |
| Total liabilities | $111.6B | $108.0B | $98.8B | $108.6B | $117.7B |
| Shareholder equity | $63.3B | $74.0B | $76.8B | $71.5B | $81.5B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.4B | $21.4B | $22.4B | $22.5B | $21.9B | $23.7B | $24.0B | $24.1B |
| Net income | $26.0B | $3.3B | $4.7B | $2.7B | $11.0B | $5.5B | $5.2B | $5.2B |
| Diluted EPS | $10.21 | $1.34 | $1.93 | $1.11 | $4.54 | $2.29 | $2.12 | $2.14 |
| Dividend / share | $1.19 | $1.19 | $1.24 | $1.24 | $1.24 | $1.30 | $1.30 | $1.30 |
Recent SEC filings
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report